Adam K. Simpson - 28 Jul 2021 Form 3 Insider Report for Icosavax, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Thomas Russo, Attorney-in Fact
Issuer symbol
N/A
Transactions as of
28 Jul 2021
Net transactions value
$0
Form type
3
Filing time
28 Jul 2021, 21:18:04 UTC
Next filing
02 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ICVX Common Stock 781,576 28 Jul 2021 By family trust F1
holding ICVX Common Stock 4,032 28 Jul 2021 By family trust
holding ICVX Common Stock 4,032 28 Jul 2021 By family trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ICVX Stock Option (Right to Buy) 28 Jul 2021 Common Stock 76,634 $0.8300 Direct F2
holding ICVX Stock Option (Right to Buy) 28 Jul 2021 Common Stock 512,534 $1.04 Direct F3
holding ICVX Stock Option (Right to Buy) 28 Jul 2021 Common Stock 1,347,546 $5.90 Direct F4
holding ICVX Stock Option (Right to Buy) 28 Jul 2021 Common Stock 375,000 $15.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 198,718 shares subject to repurchase by us, which are subject to vesting.
F2 25% of the shares subject to the option vested on 2/21/2021, and 1/48th of the shares subject to the option vest monthly thereafter.
F3 25% of the shares subject to the option will vest on 1/14/2022, and 1/48th of the shares subject to the option vest monthly thereafter.
F4 25% of the shares subject to the option will vest on 3/19/2022, and 1/48th of the shares subject to the option vest monthly thereafter.
F5 1/48th of the shares subject to the option vest monthly following July 28, 2021, the vesting commencement date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney